| Lori Ann Zundel, PT | |
|
2110 Overland Ave Ste 114, Billings, MT 59102-6440 | |
| (406) 652-8883 | |
| Not Available |
| Full Name | Lori Ann Zundel |
|---|---|
| Gender | Female |
| Speciality | Physical Therapist |
| Location | 2110 Overland Ave Ste 114, Billings, Montana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265765887 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 787 (Montana) | Primary |
| 2251G0304X | Physical Therapist - Geriatrics | 787 (Montana) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Lori Ann Zundel, PT 3205 Fairmeadow Dr, Billings, MT 59102-6520 Ph: (406) 652-3892 | Lori Ann Zundel, PT 2110 Overland Ave Ste 114, Billings, MT 59102-6440 Ph: (406) 652-8883 |
News Archive
Scientists are reporting discovery of a way to help proteins such as the new generation of protein-based drugs - sometimes heralded as tomorrow's potential "miracle cures" - get past the biochemical "Entrance Forbidden" barrier that keeps them from entering cells and doing their work. The new technique, described in the monthly journal, ACS Chemical Biology, represents a new use for an engineered form of green fluorescent protein, the topic of the 2008 Nobel Prize in Chemistry that is one of the most important research tools in biosciences.
Immunotherapy is one of the latest and most effective armaments against various types of cancers. Some of the immunotherapy drugs such as PD-1 inhibitor Keytruda from Merck can block certain proteins in the cancer cells that can make the cells invisible to the immune system normally. Some of the cancers cells can now develop other ways to disguise themselves from being killed by the immune system.
Rakesh Jain, PhD, Director of the Edwin L. Steele Laboratory for Tumor Biology at the Massachusetts General Hospital and supported by the National Foundation for Cancer Research, has discovered a novel mechanism behind the resistance to HER2- or PI3K-targeted therapies, and a treatment strategy that may overcome treatment resistance.
A team of researchers at the Karolinska University Hospital Huddinge in Stockholm, Sweden wanted to investigate if smoking status at the time of rheumatoid arthritis diagnosis was linked with pain spread or intensity.
› Verified 8 days ago
Amanda Newbern Langve, PT Physical Therapist Medicare: Medicare Enrolled Practice Location: 801 N 29th St, Billings, MT 59101 Phone: 406-238-2500 | |
Jonathan W Griffith, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 2900 12th Ave N Ste 140w, Billings, MT 59101 Phone: 406-237-5050 Fax: 406-238-6599 | |
Michael L Kelsey, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 3307 Grand Ave, Suite 203, Billings, MT 59102 Phone: 406-655-9060 Fax: 406-655-9065 | |
Garett Cohl Schild, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2825 8th Ave N, Billings, MT 59101 Phone: 406-238-2500 | |
Dr. Logan Yurt, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 4652 David Mark Trl, Billings, MT 59101 Phone: 406-861-5466 | |
Bridget Susan Cannon, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2825 8th Ave N, Billings, MT 59101 Phone: 406-238-2500 | |
Joseph Bloyder, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 2702 8th Ave N, Billings, MT 59101 Phone: 406-238-2500 |